Announcing our newest cancer test. Screen cancer early with Onco-D-clare. Learn more
Compare our trio of powerful circulating tumor cell (CTC) tests. These innovative tools leverage liquid biopsies, a simple blood test, to provide vital information about your unique cancer.
Unlike traditional biopsies that require tissue extraction, these tests offer a minimally invasive approach to gain valuable insights into your cancer's characteristics. Learn how the information returned by each test can empower you and your practitioner to make informed decisions about your treatment plan and prognosis.
The comparison below gives you an at-a-glance look at what each test focuses on, from comprehensive profiling and establishing a baseline for specific cancers to monitoring treatment response.
Provides a comprehensive picture of your cancer, including CTC count, markers associated with different cancer types (phenotype), and potential for recurrence (stemness markers).
It is ideal for understanding overall cancer progression and prognosis.
If you have a confirmed diagnosis of a specific cancer type, Oncotrail can establish a baseline of your cancer status at the beginning of treatment.
It focuses on markers relevant to your particular cancer.
This test simply checks for the presence and concentration of CTCs in your blood.
It's useful for monitoring treatment effectiveness and can be part of an interim analysis strategy.
7-10 days after sample is received
7-10 days after sample is received
7-10 days after sample is received
10-15 ml peripheral whole blood
Flow Cytometry
Flow Cytometry
Flow Cytometry
Applicable for all cancer types (except brain and CNS cancers, which require a tissue or CSF sample instead of blood sample)
(Specific for Breast, Colon, GI, Lung, Melanoma, Prostate, and Sarcoma)
Provides a comprehensive picture of your cancer, including CTC count, markers associated with different cancer types (phenotype), and potential for recurrence (stemness markers).
It is ideal for understanding overall cancer progression and prognosis.
If you have a confirmed diagnosis of a specific cancer type, Oncotrail can establish a baseline of your cancer status at the beginning of treatment.
It focuses on markers relevant to your particular cancer.
This test simply checks for the presence and concentration of CTCs in your blood.
It's useful for monitoring treatment effectiveness and can be part of an interim analysis strategy.
7-10 days after sample is received
7-10 days after sample is received
7-10 days after sample is received
7–10 ml peripheral whole blood
7–10 ml peripheral whole blood
7–10 ml peripheral whole blood
Flow Cytometry
Flow Cytometry
Flow Cytometry
All types of cancers
All types of cancers
All types of cancers
Unlike the CTC tests that focus on circulating tumor cells, our Onconomics panel of tests delves deeper into the genetic and physiological makeup of your cancer, alongside its response to various treatment options. This set of tests is a powerful tool designed to empower personalized cancer treatment plans.
The Onconomics panel of tests analyze your cancer cells on a molecular level and provide actionable insights for:
Leverage the power of our Onconomics panels to collaborate with your doctor on a treatment strategy precisely tailored to your unique cancer.
Our most comprehensive treatment testing tool that provides information to help build cancer treatment protocols for patients.
It is a combination of the Onconomics and the Onconomic Extracts tests.
A subset of the Onconomics Plus panel. Can be used to assess the effectiveness of specific cancer drugs and targeted therapies.
Also informs on the gene expression of your cancer cells.
Provides highly detailed information about how effective specific natural substances and plant extracts are, against your cancer.
Also informs on the gene expression of your cancer cells.
A subset of the Onconomics Extracts+ panel. Answers the question, “Which natural substances are most effective for targeting your cancer?”
Flow Cytometry (FACS)
Molecular biology-based assays (qPCR-microArrays)
Cell Cultures (3D)
Flow Cytometry (FACS)
Molecular biology-based assays (qPCR-microArrays)
Cell Cultures (3D)
Flow Cytometry (FACS)
Molecular biology-based assays (qPCR-microArrays)
Cell Cultures (3D)
Flow Cytometry (FACS)
Molecular biology-based assays (qPCR-microArrays)
Cell Cultures (3D)
Blood sample.
A tissue sample is required for tumors of the central nervous system.
Blood sample.
A tissue sample is required for tumors of the central nervous system.
Blood sample.
A tissue sample is required for tumors of the central nervous system.
Blood sample.
A tissue sample is required for tumors of the central nervous system.
15-25 ml peripheral whole blood.
Tissue sample qty: Minimum 400mg.
15-25 ml peripheral whole blood.
Tissue sample qty: Minimum 400mg.
15-25 ml peripheral whole blood.
Tissue sample qty: Minimum 400mg.
15-25 ml peripheral whole blood.
Tissue sample qty: Minimum 400mg.
7-10 days after sample is received
7-10 days after sample is received
7-10 days after sample is received
7-10 days after sample is received
Our most comprehensive treatment testing tool that provides information to help build cancer treatment protocols for patients.
It is a combination of the Onconomics and the Onconomic Extracts tests.
A subset of the Onconomics Plus panel. Can be used to assess the effectiveness of specific cancer drugs and targeted therapies.
Also informs on the gene expression of your cancer cells.
Provides highly detailed information about how effective specific natural substances and plant extracts are, against your cancer.
Also informs on the gene expression of your cancer cells.
A subset of the Onconomics Extracts+ panel. Answers the question, “Which natural substances are most effective for targeting your cancer?”
All types of Cancers
All types of Cancers
All types of Cancers
All types of Cancers
Flow Cytometry (FACS)
Molecular biology-based assays (qPCR-microArrays)
Cell Cultures (3D)
Flow Cytometry (FACS)
Molecular biology-based assays (qPCR-microArrays)
Cell Cultures (3D)
Flow Cytometry (FACS)
Molecular biology-based assays (qPCR-microArrays)
Cell Cultures (3D)
Flow Cytometry (FACS)
Molecular biology-based assays (qPCR-microArrays)
Cell Cultures (3D)
Blood sample.
A tissue sample is required for tumors of the central nervous system.
Blood sample.
A tissue sample is required for tumors of the central nervous system.
Blood sample.
A tissue sample is required for tumors of the central nervous system.
Blood sample.
A tissue sample is required for tumors of the central nervous system.
15–25 ml peripheral whole blood.
Qty: Minimum 400mg
15–25 ml peripheral whole blood.
Qty: Minimum 400mg.
15-25 ml peripheral whole blood.
Tissue sample qty: Minimum 400mg.
15–25 ml peripheral whole blood.
Qty: Minimum 400mg.
7-10 days after sample is received
7-10 days after sample is received
7-10 days after sample is received
7-10 days after sample is received
Start your journey to empowering information for your cancer treatment today by contacting us online.
Applicable for all cancer types (except brain and CNS cancers, which require a tissue or CSF sample instead of blood sample)